Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded encouraging developments into new therapeutic approaches. Current research centers on addressing the underlying causes of MSA. One approach under investigation involves drug-based interventions to regulate the dysregulation